310 lines
8.3 KiB
Markdown
310 lines
8.3 KiB
Markdown
# Laboratory Report Template
|
||
|
||
## Patient Information
|
||
|
||
**Patient Name:** [Last, First]
|
||
**Medical Record Number:** [MRN]
|
||
**Date of Birth:** [MM/DD/YYYY]
|
||
**Age/Sex:** [Age years, M/F]
|
||
|
||
**Ordering Physician:** [Name]
|
||
**Location:** [Inpatient unit / Outpatient clinic]
|
||
|
||
---
|
||
|
||
## Specimen Information
|
||
|
||
**Specimen Type:** [Blood / Serum / Plasma / Urine / CSF / Other]
|
||
**Collection Date/Time:** [MM/DD/YYYY at HH:MM]
|
||
**Received Date/Time:** [MM/DD/YYYY at HH:MM]
|
||
**Reported Date/Time:** [MM/DD/YYYY at HH:MM]
|
||
|
||
**Accession Number:** [Lab accession number]
|
||
**Specimen Condition:** [Acceptable / See comments]
|
||
**Fasting Status:** [Fasting / Non-fasting / Unknown] (if relevant)
|
||
|
||
---
|
||
|
||
## Laboratory Results
|
||
|
||
| Test Name | Result | Units | Reference Range | Flag |
|
||
|-----------|--------|-------|----------------|------|
|
||
| [Test] | [Value] | [Unit] | [Normal range] | [L/H/Critical] |
|
||
|
||
### Example: Complete Blood Count (CBC)
|
||
|
||
| Test | Result | Units | Reference Range | Flag |
|
||
|------|--------|-------|----------------|------|
|
||
| White Blood Cell Count | 12.5 | × 10³/μL | 4.5-11.0 | H |
|
||
| Hemoglobin | 10.2 | g/dL | 12.0-16.0 (F), 14.0-18.0 (M) | L |
|
||
| Hematocrit | 31.5 | % | 36.0-48.0 (F), 42.0-52.0 (M) | L |
|
||
| Platelet Count | 245 | × 10³/μL | 150-400 | - |
|
||
| MCV | 88.5 | fL | 80.0-100.0 | - |
|
||
| MCH | 29.5 | pg | 27.0-33.0 | - |
|
||
| MCHC | 33.2 | g/dL | 32.0-36.0 | - |
|
||
| RDW | 14.5 | % | 11.5-14.5 | - |
|
||
|
||
**Differential:**
|
||
| Cell Type | Result | Units | Reference Range | Flag |
|
||
|-----------|--------|-------|----------------|------|
|
||
| Neutrophils | 75 | % | 40-70 | H |
|
||
| Lymphocytes | 15 | % | 20-40 | L |
|
||
| Monocytes | 7 | % | 2-10 | - |
|
||
| Eosinophils | 2 | % | 1-4 | - |
|
||
| Basophils | 1 | % | 0-2 | - |
|
||
|
||
### Example: Basic Metabolic Panel (BMP)
|
||
|
||
| Test | Result | Units | Reference Range | Flag |
|
||
|------|--------|-------|----------------|------|
|
||
| Sodium | 138 | mEq/L | 136-145 | - |
|
||
| Potassium | 3.2 | mEq/L | 3.5-5.0 | L |
|
||
| Chloride | 102 | mEq/L | 98-107 | - |
|
||
| CO2 | 24 | mEq/L | 22-30 | - |
|
||
| Blood Urea Nitrogen | 28 | mg/dL | 7-20 | H |
|
||
| Creatinine | 1.8 | mg/dL | 0.6-1.2 (F), 0.7-1.3 (M) | H |
|
||
| Glucose | 145 | mg/dL | 70-100 (fasting) | H |
|
||
| eGFR | 42 | mL/min/1.73m² | >60 | L |
|
||
|
||
---
|
||
|
||
## Interpretation / Comments
|
||
|
||
[Clinical interpretation when applicable]
|
||
|
||
**Example for Anemia:**
|
||
```
|
||
Normocytic anemia with elevated WBC. Differential diagnosis includes anemia of chronic
|
||
disease, recent blood loss, or hemolysis. Consider reticulocyte count, iron studies,
|
||
and peripheral smear for further evaluation. Clinical correlation recommended.
|
||
```
|
||
|
||
**Example for Electrolyte Abnormality:**
|
||
```
|
||
Hypokalemia detected (K+ 3.2 mEq/L). Common causes include diuretic use, GI losses, or
|
||
inadequate intake. Recommend potassium repletion and follow-up testing. Moderate
|
||
azotemia present, consistent with acute kidney injury or chronic kidney disease.
|
||
Clinical correlation with patient history and prior results recommended.
|
||
```
|
||
|
||
---
|
||
|
||
## Critical Values
|
||
|
||
[If any results meet criteria for critical values]
|
||
|
||
**Critical Result:** [Test name] = [Value] [Units]
|
||
**Reference Range:** [Normal range]
|
||
**Significance:** [Life-threatening, requires immediate action]
|
||
|
||
**Notification:**
|
||
- **Called to:** [Name and title of person notified]
|
||
- **Date/Time:** [MM/DD/YYYY at HH:MM]
|
||
- **Read-back verified:** [Yes]
|
||
- **Notified by:** [Lab personnel name]
|
||
|
||
**Example Critical Values:**
|
||
- Glucose <40 mg/dL or >500 mg/dL
|
||
- Potassium <2.5 mEq/L or >6.5 mEq/L
|
||
- Sodium <120 mEq/L or >160 mEq/L
|
||
- Hemoglobin <5.0 g/dL
|
||
- Platelets <20 × 10³/μL
|
||
- WBC <1.0 × 10³/μL or >50 × 10³/μL
|
||
- INR >5.0 (on warfarin)
|
||
- Positive blood culture
|
||
- Positive CSF Gram stain
|
||
|
||
---
|
||
|
||
## Quality Control
|
||
|
||
**Specimen Quality:** [Acceptable / See note]
|
||
|
||
**QC Notes:**
|
||
- [X] Specimen collected in appropriate tube
|
||
- [X] Specimen adequately labeled
|
||
- [X] Specimen volume sufficient
|
||
- [X] No hemolysis, lipemia, or icterus
|
||
- [X] Specimen processed within acceptable time
|
||
|
||
**Issues (if any):**
|
||
- [ ] Hemolyzed - may affect [specific tests]
|
||
- [ ] Clotted - unable to perform coagulation studies
|
||
- [ ] Insufficient volume - limited testing performed
|
||
- [ ] Delayed processing - stability concerns for [specific analytes]
|
||
|
||
---
|
||
|
||
## Methodology
|
||
|
||
**Test Method:** [Instrumentation and methodology]
|
||
|
||
Examples:
|
||
- **CBC:** Automated cell counter (Sysmex XN-1000)
|
||
- **Chemistry:** Spectrophotometry (Beckman AU5800)
|
||
- **Glucose:** Enzymatic assay, hexokinase method
|
||
- **HbA1c:** HPLC (high-performance liquid chromatography)
|
||
- **Troponin:** High-sensitivity immunoassay
|
||
- **Drug levels:** Liquid chromatography-mass spectrometry (LC-MS/MS)
|
||
|
||
---
|
||
|
||
## Special Tests Examples
|
||
|
||
### Hemoglobin A1c
|
||
|
||
| Test | Result | Units | Interpretation |
|
||
|------|--------|-------|----------------|
|
||
| HbA1c | 8.5 | % | Consistent with poorly controlled diabetes |
|
||
| HbA1c | 8.5 | % (69 mmol/mol) | Target <7% for most patients |
|
||
|
||
**Reference Ranges:**
|
||
- Non-diabetic: 4.0-5.6%
|
||
- Prediabetes: 5.7-6.4%
|
||
- Diabetes diagnosis: ≥6.5%
|
||
- Treatment target: <7% (individualized)
|
||
|
||
### Lipid Panel
|
||
|
||
| Test | Result | Units | Reference Range | Desirable |
|
||
|------|--------|-------|----------------|-----------|
|
||
| Total Cholesterol | 245 | mg/dL | - | <200 |
|
||
| LDL Cholesterol | 160 | mg/dL | - | <100 |
|
||
| HDL Cholesterol | 38 | mg/dL | - | >40 (M), >50 (F) |
|
||
| Triglycerides | 235 | mg/dL | - | <150 |
|
||
| VLDL Cholesterol (calc) | 47 | mg/dL | - | <30 |
|
||
|
||
### Coagulation Studies
|
||
|
||
| Test | Result | Units | Reference Range | Flag |
|
||
|------|--------|-------|----------------|------|
|
||
| PT | 18.5 | seconds | 11.0-13.5 | H |
|
||
| INR | 2.8 | ratio | 0.8-1.2 | H |
|
||
| PTT | 42 | seconds | 25-35 | H |
|
||
|
||
**Therapeutic Ranges (INR):**
|
||
- Atrial fibrillation: 2.0-3.0
|
||
- Mechanical heart valve: 2.5-3.5
|
||
- DVT/PE treatment: 2.0-3.0
|
||
|
||
### Thyroid Function Tests
|
||
|
||
| Test | Result | Units | Reference Range | Flag |
|
||
|------|--------|-------|----------------|------|
|
||
| TSH | 8.5 | μIU/mL | 0.4-4.0 | H |
|
||
| Free T4 | 0.7 | ng/dL | 0.8-1.8 | L |
|
||
| Free T3 | 2.1 | pg/mL | 2.3-4.2 | L |
|
||
|
||
**Interpretation:** Findings consistent with primary hypothyroidism
|
||
|
||
### Urinalysis
|
||
|
||
**Physical Examination:**
|
||
- Color: [Yellow / Amber / Other]
|
||
- Clarity: [Clear / Cloudy / Turbid]
|
||
- Specific Gravity: [1.005-1.030]
|
||
|
||
**Chemical Examination:**
|
||
| Test | Result | Reference |
|
||
|------|--------|-----------|
|
||
| pH | 6.0 | 5.0-8.0 |
|
||
| Protein | Trace | Negative |
|
||
| Glucose | Negative | Negative |
|
||
| Ketones | Negative | Negative |
|
||
| Blood | 2+ | Negative |
|
||
| Bilirubin | Negative | Negative |
|
||
| Urobilinogen | Normal | Normal |
|
||
| Nitrite | Negative | Negative |
|
||
| Leukocyte Esterase | Positive | Negative |
|
||
|
||
**Microscopic Examination (if indicated):**
|
||
- WBCs: [number] /hpf (normal <5)
|
||
- RBCs: [number] /hpf (normal <3)
|
||
- Epithelial cells: [Few/Moderate/Many]
|
||
- Bacteria: [None/Few/Moderate/Many]
|
||
- Casts: [Type and number]
|
||
- Crystals: [Type if present]
|
||
|
||
---
|
||
|
||
## Microbiology Report Format
|
||
|
||
### Culture Results
|
||
|
||
**Specimen Source:** [Blood / Urine / Sputum / Wound / Other]
|
||
**Collection:** [Date and time]
|
||
|
||
**Gram Stain:**
|
||
[Results of Gram stain if performed]
|
||
Example: "Many Gram-positive cocci in clusters, many WBCs"
|
||
|
||
**Culture Results:**
|
||
|
||
**Organism:** [Identified organism]
|
||
**Quantity:** [Light / Moderate / Heavy growth] or [CFU count]
|
||
|
||
**Antimicrobial Susceptibility Testing:**
|
||
|
||
| Antibiotic | Result | MIC (μg/mL) |
|
||
|------------|--------|-------------|
|
||
| [Drug name] | S/I/R | [Value] |
|
||
|
||
Example:
|
||
| Antibiotic | Result | MIC |
|
||
|------------|--------|-----|
|
||
| Ampicillin | R | >16 |
|
||
| Ceftriaxone | S | ≤1 |
|
||
| Levofloxacin | S | 0.5 |
|
||
| Vancomycin | S | 1 |
|
||
|
||
**Interpretation:** S = Susceptible, I = Intermediate, R = Resistant
|
||
|
||
---
|
||
|
||
## Molecular/Genetic Testing
|
||
|
||
**Test:** [Specific test name]
|
||
**Method:** [PCR / Sequencing / Array / Other]
|
||
**Result:** [Detected / Not detected / Variant identified]
|
||
|
||
**Interpretation:**
|
||
[Clinical significance of result]
|
||
|
||
---
|
||
|
||
## Reference Laboratory Results
|
||
|
||
[For send-out tests]
|
||
|
||
**Test:** [Name]
|
||
**Performed by:** [Reference lab name and location]
|
||
**Result:** [Value]
|
||
**Reference Range:** [Range]
|
||
**Method:** [Methodology]
|
||
**Reported:** [Date]
|
||
|
||
---
|
||
|
||
## Laboratory Director Signature
|
||
|
||
**Medical Director:**
|
||
[Name, MD]
|
||
[Board Certifications]
|
||
[CLIA License Number]
|
||
|
||
**Electronically signed:** [Date]
|
||
|
||
---
|
||
|
||
## LOINC Codes (for interoperability)
|
||
|
||
[LOINC codes for each test when applicable for electronic reporting]
|
||
|
||
Example:
|
||
- Hemoglobin: 718-7
|
||
- Glucose: 2345-7
|
||
- Creatinine: 2160-0
|
||
- TSH: 3016-3
|
||
|
||
|